B Vitamins and Hip Fracture: Secondary Analyses and Extended Follow-Up of Two Large Randomized Controlled Trials

被引:13
|
作者
Lopez, Maria Garcia [1 ,2 ]
Bonaa, Kaare H. [3 ,4 ,5 ]
Ebbing, Marta [6 ,7 ]
Eriksen, Erik F. [1 ]
Gjesdal, Clara G. [8 ,9 ]
Nygard, Ottar [8 ,10 ]
Tell, Grethe S. [7 ]
Ueland, Per M. [8 ,11 ]
Meyer, Haakon E. [2 ,12 ]
机构
[1] Oslo Univ Hosp, Dept Clin Endocrinol Morbid Obes & Prevent Med, Oslo, Norway
[2] Univ Oslo, Inst Hlth & Soc, Dept Community Med, Oslo, Norway
[3] Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, Trondheim, Norway
[4] St Olavs Univ Hosp, Clin Heart Dis, Trondheim, Norway
[5] Arctic Univ Norway UiT, Dept Community Med, Tromso, Norway
[6] Norwegian Inst Publ Hlth, Domain Hlth Data & Digitalizat, Bergen, Norway
[7] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway
[8] Univ Bergen, Dept Clin Sci, Bergen, Norway
[9] Haukeland Hosp, Dept Rheumatol, Bergen, Norway
[10] Haukeland Hosp, Dept Heart Dis, Bergen, Norway
[11] Haukeland Hosp, Lab Clin Biochem, Bergen, Norway
[12] Norwegian Inst Publ Hlth, Domain Mental & Phys Hlth, Oslo, Norway
关键词
HIP FRACTURE; VITAMIN B-6; FOLIC ACID; VITAMIN B-12; RANDOMIZED CONTROLLED TRIAL; FOLIC-ACID SUPPLEMENTATION; BONE HEALTH; ELDERLY-MEN; CARDIOVASCULAR EVENTS; MYOCARDIAL-INFARCTION; PLASMA HOMOCYSTEINE; CANCER INCIDENCE; MORTALITY; RISK; METAANALYSIS;
D O I
10.1002/jbmr.3189
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Elevated plasma homocysteine levels are associated with increased risk of fractures in observational studies. However, it is unsettled whether homocysteine-lowering treatment affects fracture risk. The aim of this study was to investigate the effect of an intervention with B vitamins on the risk of hip fracture in a secondary analysis of combined data from two large randomized controlled trials originally designed to study cardiovascular diseases. Both trials had identical design, intervention, and primary objective. Based on a two-by-two factorial design, the intervention consisted of a daily capsule with either (1) folic acid (0.8mg) plus vitamin B-12 (0.4mg) and vitamin B-6 (40mg); (2) folic acid (0.8mg) plus vitamin B-12 (0.4mg); (3) vitamin B-6 alone (40mg); or (4) placebo. The participants were followed with respect to hip fracture during the trial or during an extended follow-up (from the trial start for each patient until the end of 2012). No statistically significant association was found between folic acid plus vitamin B-12 treatment and the risk of hip fracture, neither during the trial (median 3.3 years; hazard ratio [HR] 0.87; 95% confidence interval [CI], 0.48 to 1.59) nor during the extended follow-up (median 11.1 years; HR 1.08; 95% CI, 0.84 to 1.40). Nor were there significant differences in the risk of hip fracture between groups receiving versus not receiving vitamin B-6 during the trial (HR 1.42; 95% CI, 0.78 to 2.61). However, during the extended follow-up, those receiving vitamin B-6 showed a significant 42% higher risk of hip fracture (HR 1.42; 95% CI, 1.09 to 1.83) compared to those not receiving vitamin B-6. In conclusion, treatment with folic acid plus vitamin B-12 was not associated with the risk of hip fracture. Treatment with a high dose of vitamin B-6 was associated with a slightly increased risk of hip fracture during the extended follow-up (in-trial plus post-trial follow-up). (C) 2017 American Society for Bone and Mineral Research.
引用
收藏
页码:1981 / 1989
页数:9
相关论文
共 50 条
  • [1] Extended Follow-Up Randomized Controlled Trials
    Di Pietro, Gianluca
    Improta, Riccardo
    De Filippo, Ovidio
    Bruno, Francesco
    Birtolo, Lucia Ilaria
    Tocci, Marco
    Fabris, Tommaso
    Saade, Wael
    Colantonio, Riccardo
    Celli, Paola
    Sardella, Gennaro
    Esposito, Giovanni
    Tarantini, Giuseppe
    Mancone, Massimo
    D'Ascenzo, Fabrizio
    AMERICAN JOURNAL OF CARDIOLOGY, 2024, 224 : 56 - 64
  • [2] Combined analyses and extended follow-up of two randomized controlled homocysteine-lowering B-vitamin trials
    Ebbing, M.
    Bonaa, K. H.
    Arnesen, E.
    Ueland, P. M.
    Nordrehaug, J. E.
    Rasmussen, K.
    Njolstad, I.
    Nilsen, D. W.
    Refsum, H.
    Tverdal, A.
    Vollset, S. E.
    Schirmer, H.
    Bleie, O.
    Steigen, T.
    Midttun, O.
    Fredriksen, A.
    Pedersen, E. R.
    Nygard, O.
    JOURNAL OF INTERNAL MEDICINE, 2010, 268 (04) : 367 - 382
  • [3] Predictors of Loss to Follow-up in Hip Fracture Trials: A Secondary Analysis of the FAITH and HEALTH Trials
    Sivaratnam, Surabhi
    Comeau-Gauthier, Marianne
    Sprague, Sheila
    Schemitsch, Emil H.
    Poolman, Rudolf W.
    Frihagen, Frede
    Bhandari, Mohit
    Swiontkowski, Marc
    Bzovsky, Sofia
    JOURNAL OF ORTHOPAEDIC TRAUMA, 2020, 34 : S22 - S28
  • [4] Post-trial follow-up methodology in large randomized controlled trials: a systematic review
    Llewellyn-Bennett, Rebecca
    Edwards, Danielle
    Bulbulia, Richard
    Bowman, Louise
    TRIALS, 2017, 18
  • [5] Long-term follow-up and large patient cohorts:: A substitute for randomized controlled trials?
    Curtis, J. J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 (03) : 483 - 484
  • [6] Osteoporotic hip fracture outcome. A two year follow-up
    Malouf, J
    Laiz, AM
    Marin, AM
    Longobardi, V
    Farrerons, J
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 357 - 357
  • [7] Post-trial follow-up methodology in large randomized controlled trials: A systematic review protocol
    Llewellyn-Bennett R.
    Bowman L.
    Bulbulia R.
    Systematic Reviews, 5 (1)
  • [8] Primary and secondary prevention of coronary artery disease: a follow-up on clinical controlled trials
    Kornitzer, M
    CURRENT OPINION IN LIPIDOLOGY, 1998, 9 (06) : 557 - 564
  • [9] Extended follow-up of a randomized controlled trial of the Lidcombe Program of Early Stuttering Intervention
    Jones, Mark
    Onslow, Mark
    Packman, Ann
    O'Brian, Sue
    Hearne, Anna
    Williams, Shelley
    Ormond, Tika
    Schwarz, Ilsa
    INTERNATIONAL JOURNAL OF LANGUAGE & COMMUNICATION DISORDERS, 2008, 43 (06) : 649 - 661
  • [10] Loss to Follow-up in Head and Neck Cancer: A Systematic Review of Randomized Controlled Trials
    Sawaf, Tuleen
    Quinton, Brooke A.
    Moss, Gabriel
    Yaffe, Noah M.
    Quereshy, Humzah A.
    Cabrera-Aviles, Claudia
    Fowler, Nicole
    Li, Shawn
    Thuener, Jason E.
    Lavertu, Pierre
    Rezaee, Rod P.
    Teknos, Theodoros N.
    Tamaki, Akina
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2023, 169 (04) : 747 - 754